{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:06:58Z","timestamp":1760054818499,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.respe.2015.12.019","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T15:14:06Z","timestamp":1464275646000},"page":"185-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Public health impact of Infanrix hexa\u2122 (DTPa-HBV-IPV\/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants\u2019 vaccination against hepatitis B in general and pediatric practices\u00a0\u2013\u00a0the PRALINE study"],"prefix":"10.1016","volume":"64","author":[{"given":"F.","family":"Vi\u00e9 le Sage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gaudelus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Texier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pouriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sch\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Tehard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Br\u00e9art","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.respe.2015.12.019_bib0120","first-page":"225","article-title":"\u00c9valuation de la couverture du programme de vaccination h\u00e9patite B dans les coll\u00e8ges","volume":"51","author":"RNSP","year":"1997","journal-title":"Bull Epidemiol Hebd (Paris)"},{"year":"2012","series-title":"Mesure de la couverture vaccinale en France. Sources de donn\u00e9es et donn\u00e9es actuelles","author":"Guthmann","key":"10.1016\/j.respe.2015.12.019_bib0125"},{"key":"10.1016\/j.respe.2015.12.019_bib0130","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/brain\/awl368","article-title":"Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination","volume":"130","author":"Mikaeloff","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.respe.2015.12.019_bib0135","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1212\/01.wnl.0000335762.42177.07","article-title":"Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood","volume":"72","author":"Mikaeloff","year":"2009","journal-title":"Neurology"},{"year":"2012","series-title":"Bilan de pharmacovigilance et profil de s\u00e9curit\u00e9 d\u2019emploi des vaccins contre l\u2019h\u00e9patite B","author":"AFSSAPS","key":"10.1016\/j.respe.2015.12.019_bib0140"},{"year":"2010","series-title":"Estimation des couvertures vaccinales en secteur lib\u00e9ral \u00e0 travers l\u2019\u00e9chantillon g\u00e9n\u00e9raliste des b\u00e9n\u00e9ficiaires en France 2004\u20132009","author":"Fonteneau","key":"10.1016\/j.respe.2015.12.019_bib0145"},{"key":"10.1016\/j.respe.2015.12.019_bib0150","first-page":"557","article-title":"Couverture vaccinale du vaccin pneumococcique heptavalent conjugu\u00e9 en 2006\u00a0et comparaison avec les autres vaccins p\u00e9diatriques du calendrier vaccinal\u00a0: analyse des carnets de sant\u00e9","volume":"26","author":"Cohen","year":"2006","journal-title":"Med Enfance"},{"year":"2009","series-title":"Principales recommandations et propositions en vue de la prochaine loi pour une politique de sant\u00e9 publique","author":"Haut Conseil de la Sant\u00e9 Publique","key":"10.1016\/j.respe.2015.12.019_bib0155"},{"key":"10.1016\/j.respe.2015.12.019_bib0160","first-page":"257","article-title":"Vaccinoscopie\u00a0: couverture vaccinale vis-\u00e0-vis de l\u2019h\u00e9patite B en 2010","volume":"6","author":"Gaudelus","year":"2011","journal-title":"Med Enfance"},{"key":"10.1016\/j.respe.2015.12.019_bib0165","first-page":"339","article-title":"Opinions et pratiques des m\u00e9decins g\u00e9n\u00e9ralistes vis-\u00e0-vis de la vaccination contre l\u2019h\u00e9patite B, France, 2009. [General practitioners\u2019 opinions and practices on hepatitis B vaccination, France, 2009]","volume":"29\u201330","author":"Gautier","year":"2012","journal-title":"Bull Epidemiol Hebd (Paris)"},{"key":"10.1016\/j.respe.2015.12.019_bib0170","first-page":"271","article-title":"Calendrier vaccinal 2007\u00a0et avis publi\u00e9s depuis le calendrier vaccinal 2006. [Vaccination schedule for 2007 and recommendations published since the 2006 vaccination schedule]","volume":"31\u201332","author":"Haut Conseil de la Sant\u00e9 Publique","year":"2007","journal-title":"Bull Epidemiol Hebd (Paris)"},{"year":"2005","series-title":"Barom\u00e8tre sant\u00e9 m\u00e9decins\/pharmaciens 2003","author":"Gautier","key":"10.1016\/j.respe.2015.12.019_bib0175"},{"key":"10.1016\/j.respe.2015.12.019_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/S0398-7620(06)76769-4","article-title":"Perceptions de la vaccination contre l\u2019h\u00e9patite B en France. Analyse de trois enqu\u00eates. [Perceptions of hepatitis B vaccination in France. Analysis of three surveys]","volume":"54","author":"Balinska","year":"2006","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.respe.2015.12.019_bib0185","first-page":"8","article-title":"D\u00e9pistage et vaccination\u00a0: ce qu\u2019en pensent les m\u00e9decins","volume":"131","author":"Jestin","year":"2009","journal-title":"Concours Med"},{"year":"2002","series-title":"Avis de la commission du 10\u00a0juillet 2002\u00a0sur Infanrix hexa\u2122","author":"Haute Autorit\u00e9 de la sant\u00e9","key":"10.1016\/j.respe.2015.12.019_bib0190"},{"key":"10.1016\/j.respe.2015.12.019_bib0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.respe.2015.11.007","article-title":"Public health impact of Infanrix hexa\u2122 (DTPa-HBV-IPV\/Hib) reimbursement: a study programme in France. Part 1: evolution of hepatitis B vaccine coverage rates in infants aged less than 27months, in the general population - the PopCorn study","volume":"64","author":"Gaudelus","year":"2016","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.respe.2015.12.019_bib0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.arcped.2011.11.010","volume":"19","author":"Partouche","year":"2012","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.respe.2015.12.019_bib0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.medmal.2011.04.002","article-title":"Determinants of vaccination coverage for children and teenagers","volume":"41","author":"Laval","year":"2011","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.respe.2015.12.019_bib0210","first-page":"499","volume":"26\u201327","author":"Guthmann","year":"2015","journal-title":"Bull Epidemiol Hebd (Paris)"},{"key":"10.1016\/j.respe.2015.12.019_bib0215","first-page":"492","article-title":"Vaccination contre l\u2019h\u00e9patite B\u00a0: perceptions et pratiques des m\u00e9decins g\u00e9n\u00e9ralistes, France, 2014. [Hepatitis B vaccination: perceptions and practices of general practitioners, France, 2014]","volume":"26\u201327","author":"Gautier","year":"2015","journal-title":"Bull Epidemiol Hebd (Paris)"},{"key":"10.1016\/j.respe.2015.12.019_bib0220","first-page":"485","article-title":"Les r\u00e9ticences des parents face \u00e0 la vaccination contre l\u2019h\u00e9patite B en France\u00a0: une enqu\u00eate en ligne aupr\u00e8s de 5922\u00a0parents, 2013. [Parents hesitancy toward hepatitis B vaccination in France: an online survey of 5922 parents, 2013]","volume":"26\u201327","author":"Limousi","year":"2015","journal-title":"Bull Epidemiol Hebd (Paris)"},{"key":"10.1016\/j.respe.2015.12.019_bib0225","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.arcped.2013.05.016","volume":"20","author":"Martinot","year":"2013","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.respe.2015.12.019_bib0230","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.medmal.2013.06.016","article-title":"Evolution of hepatitis B vaccine coverage rates in France between 2008 and 2011","volume":"43","author":"Denis","year":"2013","journal-title":"Med Mal Infect"}],"container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762016301523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762016301523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:38:16Z","timestamp":1759970296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0398762016301523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0398762016301523"],"URL":"https:\/\/doi.org\/10.1016\/j.respe.2015.12.019","relation":{},"ISSN":["0398-7620"],"issn-type":[{"type":"print","value":"0398-7620"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Public health impact of Infanrix hexa\u2122 (DTPa-HBV-IPV\/Hib) reimbursement: A study programme in France. Part 2: Evolution of the acceptability of infants\u2019 vaccination against hepatitis B in general and pediatric practices\u00a0\u2013\u00a0the PRALINE study","name":"articletitle","label":"Article Title"},{"value":"Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.respe.2015.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}